IV Flush Syringe Market Growth 2025: Global Supplain Chain Developments, Outlook in GCC and MEA | SPM Medicare, Nipro Medical Corporation, B. Braun SE, Cardinal Health, Vygon

IV Flush Syringe Market reached US$ 0.49 billion in 2024 and is expected to reach US$ 0.80 billion by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/iv-flush-syringe-market?kb

United States: Recent Industry Developments

✅ October 2025: BD (Becton Dickinson) introduced pre-filled IV flush syringes with enhanced sterility safeguards to minimize catheter-related infection risks.

✅ September 2025: ICU Medical expanded its IV flush syringe distribution network to address rising demand in outpatient infusion centers.

✅ August 2025: U.S. hospitals increased adoption of saline pre-filled flush syringes to reduce medication errors and improve clinical workflow efficiency.

Japan: Recent Industry Developments

✅ October 2025: Terumo Corporation launched safety-engineered IV flush syringes designed to reduce needlestick injuries for nurses and clinicians.

✅ September 2025: Growing usage of pre-filled heparin flush syringes in Japan for long-term catheter maintenance in dialysis and oncology care settings.

✅ August 2025: Collaboration between Japanese hospitals and syringe manufacturers accelerated localization of IV flush syringe production to ensure stable supply.

Major Growing Players:

BD, Medline Industries, LP, ICU Medical, Inc., Terumo Corporation, SPM Medicare, Nipro Medical Corporation, B. Braun SE, Cardinal Health, Vygon, Teleflex Incorporated among others.

Emerging Players

Aquabiliti, Polymedicure, and Medefil, Inc

Latest M&A

1. BD's planned 2025 spin-off of Biosciences/Diagnostics creates focused medtech entity prioritizing flush syringes alongside ICU Medical-Otsuka $200M JV for 1.4B IV units/year.​

2. B. Braun's DUPLEX dual-chamber clearance bolsters combo flush/therapy positioning; ICU Medical expands via partnerships amid consolidation wave.​

Forecast Projection:

The Global IV Flush Syringe Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Global IV Flush Syringe Market report is built on solid intelligence - powered by both primary and secondary research. Our analysts have deep-dived into every factor that can influence your business roadmap, including government regulations, competitive landscape, tech innovations, historical market behavior, upcoming breakthroughs, adjacent industry trends, market volatility, growth prospects, and potential risks.

Government Regulations

1. FDA shortage list: Prefilled saline flushes (NGT code) remain listed; conservation strategies urged amid ongoing gaps despite saline shortage end (Aug 2025).​

2. TGA (Australia): Persistent IV fluid/flush shortages prompt import waivers and stockpiling guidelines.​

3. India NCDC IPC guidelines: Mandate sterile single-use flushes per line; chlorine flushing protocols for disposal. Strict sterility/labeling drives compliance costs.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=iv-flush-syringe-market?kb

Key Segments:

BD, Medline Industries, LP, ICU Medical, Inc., Terumo Corporation, SPM Medicare, Nipro Medical Corporation, B. Braun SE, Cardinal Health, Vygon, Teleflex Incorporated

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: sets the stage by defining the full scope of the report and delivering an executive summary of key market segments across regions, product types, and applications. It provides a comprehensive snapshot of current market sizes and reveals future growth potential, offering a clear vision of how the market will evolve in the short, mid, and long term.

Chapter 2: uncovers critical insights and highlights the most impactful emerging trends shaping the IV Flush Syringe market's future - essential knowledge for investors and strategists looking to stay ahead.

Chapter 3: dives deep into the competitive landscape, delivering an in-depth analysis of IV Flush Syringe manufacturers. It covers market share dynamics, strategic developments, and the latest mergers and acquisitions that are redefining the industry.

Chapter 4: profiles the market's leading players, offering detailed views of their revenue streams, profit margins, product portfolios, and recent innovations - arming you with the intel to benchmark and strategize effectively.

Chapters 5 & 6: break down revenue performance by region and country, providing a quantitative analysis that spotlights growth hotspots, development prospects, and the unique opportunities each market offers across the globe.

Chapter 7: explores market segmentation by type, revealing the size and untapped potential of each segment - guiding you toward lucrative "blue ocean" opportunities that competitors may have overlooked.

Chapter 8: analyzes the market by application, evaluating downstream sectors with the highest growth potential and identifying promising areas for expansion and investment.

Chapter 9: maps the entire industry supply chain, tracing upstream suppliers to downstream distributors, giving you full visibility into critical business linkages and value drivers.

Chapter 10: wraps up with a powerful summary of the report's key findings and strategic takeaways, delivering the must-know insights every industry stakeholder needs to make confident, forward-looking decisions.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/iv-flush-syringe-market?kb

Supply Chain

Demand: Chronic disease surge (diabetes/cardio/cancer) + aging populations fuel IV therapy; saline dominates 82% share, heparin fastest-growing (6.43% CAGR) for oncology ports.​
Supply Issues:

1. Saline API gaps (Baxter storm 2024 removed US capacity); resin/plastic shortages; 2025 US tariffs on imports exacerbate backorders.​

2. Recalls: Dialysis syringes (2023 contamination) cascaded to flushes; hospitals ration, delay surgeries.​

3. Mitigation: BD $35M Nebraska expansion (+50 jobs); distributed manufacturing; safety stock buildup. Market $341M (2024) → $544M (2032).

Related Reports:

Prefilled Syringes Market: https://www.datamintelligence.com/download-sample/pre-filled-syringes-market?kb

Pre-filled Flush Syringes Market: https://www.datamintelligence.com/download-sample/pre-filled-flush-syringes-market?kb

Disposable Syringes Market: https://www.datamintelligence.com/download-sample/disposable-syringes-market?kb

APAC and MENA Prefilled Syringes Market: https://www.datamintelligence.com/download-sample/apac-and-mena-prefilled-syringes-market?kb

Safety Syringes Market: https://www.datamintelligence.com/download-sample/safety-syringes-market?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.